Cancer Research Donn Young  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, X.-Y.
Right arrow Articles by Prochownik, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, X.-Y.
Right arrow Articles by Prochownik, E. V.
[Cancer Research 61, 6487-6493, September 1, 2001]
© 2001 American Association for Cancer Research


Molecular Biology and Genetics

Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression1

Xiao-Ying Yin, Linette Grove, Nabanita S. Datta, Karen Katula, Michael W. Long and Edward V. Prochownik2

Section of Hematology/Oncology, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania [X-Y. Y., L. G., E. V. P.]; Section of Hematology/Oncology, Department of Pediatrics, The University of Michigan School of Medicine, Ann Arbor, Michigan [N. D., M. W. L.]; Department of Biology, The University of North Carolina, Greensboro, Greensboro, North Carolina [K. K.]; The University of Michigan Cancer Center [M. W. L.] and The Cellular and Molecular Biology Program [M. W. L., E. V. P.], The University of Michigan Medical Center, Ann Arbor, Michigan; The Department of Molecular Genetics and Biochemistry, The University of Pittsburgh Medical Center [M. W. L., E. V. P.] and The University of Pittsburgh Cancer Institute [E. V. P.], Pittsburgh, Pennsylvania 15213

We have shown previously that mitotic spindle inhibitors allow the c-Myconcoprotein to uncouple mitosis from DNA synthesis, resulting in the acquisition of tetraploidy. This can also occur in the absence of spindle inhibition if c-Myc deregulation is combined with inactivation of the p53 tumor suppressor. Under these conditions, cyclin B1 protein is induced but retains its normal cell cycle regulation. We now show that the cyclin B1 promoter is directly but oppositely regulated by c-Myc and p53. Enforced expression of cyclin B1 also induces tetraploidy, either after mitotic spindle inhibition or in the absence of such inhibition if cyclin B1 is coexpressed with c-Myc. Cyclin B1 represents a new class of c-Myc target genes that is also regulated by p53. It is also the first identified downstream effector of c-Myc able to produce the chromosomal instability that characterizes virtually all tumor cells.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Agarwal, A.-M. Gonzalez-Angulo, S. Myhre, M. Carey, J.-S. Lee, J. Overgaard, J. Alsner, K. Stemke-Hale, A. Lluch, R. M. Neve, et al.
Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Clin. Cancer Res., June 1, 2009; 15(11): 3654 - 3662.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, J. Lu, and E. V. Prochownik
Modularity of the Oncoprotein-like Properties of Platelet Glycoprotein Ib{alpha}
J. Biol. Chem., January 16, 2009; 284(3): 1410 - 1418.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R. Seo, J. Kim, S. Bae, J.-W. Soh, and Y.-S. Lee
Cdk5-mediated Phosphorylation of c-Myc on Ser-62 Is Essential in Transcriptional Activation of Cyclin B1 by Cyclin G1
J. Biol. Chem., June 6, 2008; 283(23): 15601 - 15610.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Macias, Y. Kim, P. L. Miliani de Marval, A. Klein-Szanto, and M. L. Rodriguez-Puebla
Cdk2 Deficiency Decreases ras/CDK4-Dependent Malignant Progression, but Not myc-Induced Tumorigenesis
Cancer Res., October 15, 2007; 67(20): 9713 - 9720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Ghosh, R. Steele, and R. B. Ray
Knockdown of MBP-1 in Human Prostate Cancer Cells Delays Cell Cycle Progression
J. Biol. Chem., August 18, 2006; 281(33): 23652 - 23657.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik
Deregulation of common genes by c-Myc and its direct target, MT-MC1
PNAS, December 27, 2005; 102(52): 18968 - 18973.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Roh, C. Song, J. Kim, and S. A. Abdulkadir
Chromosomal Instability Induced by Pim-1 Is Passage-dependent and Associated with Dysregulation of Cyclin B1
J. Biol. Chem., December 9, 2005; 280(49): 40568 - 40577.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Rothermund, K. Rogulski, E. Fernandes, A. Whiting, J. Sedivy, L. Pu, and E. V. Prochownik
C-Myc-Independent Restoration of Multiple Phenotypes by Two C-Myc Target Genes with Overlapping Functions
Cancer Res., March 15, 2005; 65(6): 2097 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Kamasani, M. Huang, J. B. DuHadaway, E. V. Prochownik, P. S. Donover, and G. C. Prendergast
Cyclin B1 Is a Critical Target of RhoB in the Cell Suicide Program Triggered by Farnesyl Transferase Inhibition
Cancer Res., November 15, 2004; 64(22): 8389 - 8396.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Garcia-Muse, G. Steinberg, and J. Perez-Martin
Characterization of B-type cyclins in the smut fungus Ustilago maydis: roles in morphogenesis and pathogenicity
J. Cell Sci., January 22, 2004; 117(3): 487 - 506.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K.-H. Baek, H.-J. Shin, J.-K. Yoo, J.-H. Cho, Y.-H. Choi, Y.-C. Sung, F. McKeon, and C.-W. Lee
p53 deficiency and defective mitotic checkpoint in proliferating T lymphocytes increase chromosomal instability through aberrant exit from mitotic arrest
J. Leukoc. Biol., June 1, 2003; 73(6): 850 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. S. Yoon, X. Chen, and V. W. Yang
Kruppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage
J. Biol. Chem., January 17, 2003; 278(4): 2101 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Kohn, N. D. Ruth, M. K. Brown, M. Livingstone, and A. Eastman
Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C Activation
J. Biol. Chem., July 12, 2002; 277(29): 26553 - 26564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. A. McGrath-Morrow and J. Stahl
Inhibition of Glutamine Synthetase in A549 Cells During Hyperoxia
Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Yin, L. Grove, K. Rogulski, and E. V. Prochownik
Myc Target in Myeloid Cells-1, a Novel c-Myc Target, Recapitulates Multiple c-Myc Phenotypes
J. Biol. Chem., May 24, 2002; 277(22): 19998 - 20010.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.